RESPONSES TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN ADULTS 70–79 WITH CHRONIC DISEASES

Many countries recommend that adults with chronic disease be vaccinated with pneumococcal polysaccharide vaccine (PPSV23) because of their increased risk for pneumococcal disease. To explore the immunogenicity of PPSV23 in these patients we examined antibody responses in adults age 70–89 with chroni...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Innov Aging
Hlavní autoři: Kawakami, K., Kishino, H., Kanazu, S., Toshimizu, N., Yokokawa, R., Takahashi, K., Kohn, M., Musey, L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6242514/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igx004.788
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky